Auransa, Inc.,an AI biotech and Polaris Quantum Biotech (Polarisqb), a quantum based drug design company, announce progress on important breast cancer target.
POLARISqb and Auransa Announce Promising Results for Triple Negative Breast Cancer using Quantum Computing and AI
Previous
Previous
FDA Acceptance of Auransa's IND Application for AU409 for Treatment of Patients with Hepatocellular Carcinoma
Next
Next